• Home
• About Us
• POP Guides
• Translations
• Library
• Learning Center
• POP Conference

Search: Search Entire Site Search Problem Guides Search Response Guides Search Tool Guides Crime Prevention Studies Goldstein Reports Tilley Reports

POP Center » Problems » Prescription Fraud » Endnotes

Endnotes

[1] National Drug Intelligence Center (2000).[Full Text ]

[2] National Drug Strategy Network (1996). [Full Text ]

[3] Zickler (2001). [Full Text ]

[4] Mitka (2000).

[5] Mitka (2000).

[6] Payne and Dabney (1997).

[7] Substance Abuse and Mental Health Services Administration (2002b). [Full Text ]

[8] Substance Abuse and Mental Health Services Administration (2003). [Full Text ]

[9] Substance Abuse and Mental Health Services Administration (2003). [Full Text ]

[10] Substance Abuse and Mental Health Services Administration (2002a). [Full Text ]

[11] Palm Beach County Sheriff’s Department (2003). [Full Text ]

[12] National Drug Intelligence Center (2000). [Full Text ]

[13] Substance Abuse and Mental Health Services Administration (2003). [Full Text ]

[14] Substance Abuse and Mental Health Services Administration (2003). [Full Text ]

[15] Ramer (2001). [Full Text ]

[16] National Drug Intelligence Center (2001b). [Full Text ]

[17] Kalb (2001).

[18] Schober (2001). [Full Text ]

[19] Ramer (2001). [Full Text ]

[20] Mitka (2000).

[21] National Institute on Drug Abuse (2002). [Full Text ]

[22] Substance Abuse and Mental Health Services Administration (2003). [Full Text ]

[23] Ramer (2001). [Full Text ]

[24] National Drug Intelligence Center (2000). [Full Text ]

[25] National Institute on Drug Abuse (2002). [Full Text ]

[26] National Institute on Drug Abuse (2002). [Full Text ]

[27] National Institute on Drug Abuse (2002). [Full Text ]

[28] Mitka (2000).

[29] National Institute on Drug Abuse (2002). [Full Text ]

[30] National Drug Intelligence Center (2000). [Full Text ]

[31] Ramer (2001). [Full Text ]

[32] Aiken (2001). [Full Text ]

[33] U.S. Drug Enforcement Administration (2000b).[Full Text ]

[34] Wilford (1990).

[35] Fountain et al. (1997).

[36] Fountain et al. (1997).

[37] National Drug Intelligence Center (2001a). [Full Text ]

[38] U.S. Drug Enforcement Administration (2000b). [Full Text ]

[39] Wick (1995).

[40] Clarke (1997).

[41] National Association of State Controlled Substances Authorities and Alliance of States With Prescription Monitoring Programs (2002). [Full Text ]

[42] UK Department of Health (1998). [Full Text ]

[43] Middleton (2000). [Full Text ]

[44] Joranson et al. (2002); U.S. Drug Enforcement Administration (2000a) [Full Text ]; U.S. General Accounting Office (1992[Full Text ], 2002[Full Text ]).

[45] Cooper et al. (1993). [Full Text ]

[46] Cooper et al. (1993). [Full Text ]

[47] Forgione, Neuenschwander, and Vermeer (2001).

[48] Florida Department of Law Enforcement (2001). [Full Text ]

[49] Wesson and Smith(1990). [Full Text ]

[50] Wessonand Smith(1990). [Full Text ]

[51] Goetz (2001). [Full Text ]